Twist Bioscience: AI Designs Increasingly More Proteins - This DNA Specialist Provides the Shovels for the Biotech Boom
Reading Time: 3 minutes
AI is increasingly able to digitally design protein and DNA sequences. However, every promising sequence must then be physically produced and tested in the lab. At this interface, Twist Bioscience positions itself, and Leerink sees AI-driven drug discovery as still at the very beginning of its growth curve. AI designs – Twist translates models into real biology Twist produces synthetic DNA on its own silicon platform and also offers protein expression as well as antibody and characterization services. AI companies can thus translate digital...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

